Home » Stocks » VolitionRX

VolitionRX Limited (VNRX)

Stock Price: $3.23 USD -0.22 (-6.38%)
Updated Aug 6, 2020 4:00 PM EDT - Market closed
Pre-market: $3.30 +0.07 (2.17%) Aug 7, 8:24 AM

Stock Price Chart

Key Info

Market Cap 149.31M
Revenue (ttm) 17,640
Net Income (ttm) -17.75M
Shares Out 46.23M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $3.23
Previous Close $3.45
Change ($) -0.22
Change (%) -6.38%
Day's Open 3.45
Day's Range 3.18 - 3.45
Day's Volume 166,930
52-Week Range 2.22 - 6.84

More Stats

Market Cap 149.31M
Enterprise Value 141.01M
Earnings Date (est) Aug 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 46.23M
Float 21.40M
EPS (basic) -0.43
EPS (diluted) -0.44
FCF / Share -0.36
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.39M
Short Ratio 1.20
Short % of Float 4.92%
Beta 1.82
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 8,464.36
PB Ratio 16.51
Revenue 17,640
Operating Income -17.90M
Net Income -17.75M
Free Cash Flow -14.62M
Net Cash 8.30M
Net Cash / Share 0.18
Gross Margin 96.92%
Operating Margin -101,457.39%
Profit Margin -100,595.50%
FCF Margin -82,864.56%
ROA -59.75%
ROE -146.15%
ROIC -462.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 4
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$7.75*
(139.94% upside)
Low
6.00
Current: $3.23
High
10.00
Target: 7.75
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue0.02------0.05--
Gross Profit0.02------0.05--
Operating Income-16.04-17.90-14.70-12.43-10.01-5.95-4.58-4.08-2.61-0.01
Net Income-16.10-18.01-14.77-11.91-9.53-8.21-3.71-4.08-2.61-0.01
Shares Outstanding39.1831.3926.3923.0517.7313.4410.839.365.772.29
Earnings Per Share-0.41-0.57-0.56-0.52-0.54-0.61-0.34-0.44-0.45-0.01
Operating Cash Flow-12.74-14.73-12.19-8.86-8.55-4.14-3.08-2.31-1.65-
Capital Expenditures-0.51-0.30-1.43-0.42-0.08-0.30--0.09-0.03-
Free Cash Flow-13.25-15.03-13.62-9.28-8.62-4.44-3.08-2.41-1.69-
Cash & Equivalents16.9713.4310.1221.685.922.140.890.380.350.00
Total Debt3.943.272.771.470.38--0.050.160.02
Net Cash / Debt13.0310.167.3520.215.532.140.890.320.19-0.02
Assets21.2917.4914.6224.737.713.432.072.222.25-
Liabilities7.095.354.673.561.673.061.391.381.160.11
Book Value14.2012.149.9621.186.040.370.680.831.09-0.11
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name VolitionRX Limited
Country United States
Employees 50
CEO Cameron John Reynolds

Stock Information

Ticker Symbol VNRX
Stock Exchange NYSE American
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NYSEAMERICAN: VNRX

Description

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company develops blood-based Nu.Q immunoassays to detect specific biomarkers. VolitionRx Limited is headquartered in Austin, Texas.